Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
Depression
Diabetic kidney disease
Dietary fiber
Lifestyle
Physical activity
Prospective study
Journal
Clinical and experimental nephrology
ISSN: 1437-7799
Titre abrégé: Clin Exp Nephrol
Pays: Japan
ID NLM: 9709923
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
23
07
2021
accepted:
15
09
2021
pubmed:
29
9
2021
medline:
5
4
2022
entrez:
28
9
2021
Statut:
ppublish
Résumé
Epidemiological data regarding diabetic kidney disease are accumulated insufficiently in Japan. We prospectively investigated the incidence of end-stage renal disease (ESRD) and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes. 4904 participants with type 2 diabetes (mean age 65 years, mean estimated glomerular filtration rate (eGFR) 75 mL/min/1.73 m The incidence rates of ESRD and all-cause mortality were 4.1/1000 person-years and 12.3/1000 person-years, respectively, and increased according to stages of chronic kidney disease (eGFR < 30 mL/min/1.73 m This prospective study has emphasized the importance of multifactorial interventions on risk factors to suppress the high incidence of ESRD in Japanese patients with type 2 diabetes.
Sections du résumé
BACKGROUND
BACKGROUND
Epidemiological data regarding diabetic kidney disease are accumulated insufficiently in Japan. We prospectively investigated the incidence of end-stage renal disease (ESRD) and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes.
METHODS
METHODS
4904 participants with type 2 diabetes (mean age 65 years, mean estimated glomerular filtration rate (eGFR) 75 mL/min/1.73 m
RESULTS
RESULTS
The incidence rates of ESRD and all-cause mortality were 4.1/1000 person-years and 12.3/1000 person-years, respectively, and increased according to stages of chronic kidney disease (eGFR < 30 mL/min/1.73 m
CONCLUSIONS
CONCLUSIONS
This prospective study has emphasized the importance of multifactorial interventions on risk factors to suppress the high incidence of ESRD in Japanese patients with type 2 diabetes.
Identifiants
pubmed: 34581896
doi: 10.1007/s10157-021-02136-2
pii: 10.1007/s10157-021-02136-2
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
122-131Subventions
Organisme : the japan society for the promotion of science
ID : 23249037
Organisme : the japan society for the promotion of science
ID : 23659353
Organisme : the japan society for the promotion of science
ID : 16K00861
Organisme : the japan society for the promotion of science
ID : 19K24229
Organisme : the japan society for the promotion of science
ID : 21K11700
Organisme : the japan society for the promotion of science
ID : 20K19663
Informations de copyright
© 2021. Japanese Society of Nephrology.
Références
The Japanese Society for Dialysis Therapy Renal Data Registry. https://docs.jsdt.or.jp/overview/file/2019/pdf/2019all.pdf 2021 Accessed on 21 May 2021
United States Renal Data System. 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020.
Ueki K, Sasako T, Okazaki Y, Miyake K, Nangaku M, Ohashi Y, et al. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney Int. 2021;99:256–66. https://doi.org/10.1016/j.kint.2020.08.012 .
doi: 10.1016/j.kint.2020.08.012
pubmed: 32891604
Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, et al. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2014;18:613–20. https://doi.org/10.1007/s10157-013-0879-4 .
doi: 10.1007/s10157-013-0879-4
pubmed: 24132561
Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, et al. Risk factors for CKD progression in Japanese patients: findings from the chronic kidney disease japan cohort (CKD-JAC) study. Clin Exp Nephrol. 2017;21:446–56. https://doi.org/10.1007/s10157-016-1309-1 .
doi: 10.1007/s10157-016-1309-1
pubmed: 27412450
Hoshino J, Tsunoda R, Nagai K, Kai H, Saito C, Ito Y, et al. Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b–5: results from a REACH-J CKD cohort study. Clin Exp Nephrol. 2021;25:902–10. https://doi.org/10.1007/s10157-021-02059-y .
doi: 10.1007/s10157-021-02059-y
pubmed: 33881641
Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014. JAMA. 2016;316:602–10. https://doi.org/10.1001/jama.2016.10924 .
doi: 10.1001/jama.2016.10924
pubmed: 27532915
pmcid: 5444809
Kume S, Araki SI, Ugi S, Morino K, Koya D, Nishio Y, et al. Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014. J Diabetes Investig. 2019;10:1032–40. https://doi.org/10.1111/jdi.12977 .
doi: 10.1111/jdi.12977
pubmed: 30451386
pmcid: 6626952
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO. Clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;2020(98):S1-115. https://doi.org/10.1016/j.kint.2020.06.019 .
doi: 10.1016/j.kint.2020.06.019
Ide H, Iwase M, Fujii H, Ohkuma T, Kaizu S, Jodai T, et al. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry. Clin Exp Nephrol. 2017;21(383–90):2016. https://doi.org/10.1007/s10157-016-1296-2 .
doi: 10.1007/s10157-016-1296-2
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92. https://doi.org/10.1053/j.ajkd.2008.12.034 .
doi: 10.1053/j.ajkd.2008.12.034
pubmed: 19339088
Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16:97–103. https://doi.org/10.1038/sj.jhh.1001307 .
doi: 10.1038/sj.jhh.1001307
pubmed: 11850766
Kanda E, Kashihara N, Matsushita K, Usui T, Okada H, Iseki K, et al. Guidelines for clinical evaluation of chronic kidney disease: AMED research on regulatory science of pharmaceuticals and medical devices. Clin Exp Nephrol. 2018;22:1446–75. https://doi.org/10.1007/s10157-018-1615-x .
doi: 10.1007/s10157-018-1615-x
pubmed: 30006871
Cheng H-T, Xu X, Lim PS, Hung K-Y. Worldwide epidemiology of diabetes-related end-stage renal disease, 2000–2015. Diabetes Care. 2021;44:89–97. https://doi.org/10.2337/dc20-1913 .
doi: 10.2337/dc20-1913
pubmed: 33203706
Oshima M, Toyama T, Haneda M, Furuichi K, Babazono T, Yokoyama H, et al. Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes. PLoS ONE. 2018;13: e0201535. https://doi.org/10.1371/journal.pone.0201535 .
doi: 10.1371/journal.pone.0201535
pubmed: 30071057
pmcid: 6072050
Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225–32. https://doi.org/10.1046/j.1523-1755.2003.00712.x .
doi: 10.1046/j.1523-1755.2003.00712.x
pubmed: 12472787
Swartling O, Rydell H, Stendahl M, Segelmark M, Lagerros YT, Evans M. CKD progression and mortality among men and women: a nationwide study in Sweden. Am J Kidney Dis. 2021. https://doi.org/10.1053/j.ajkd.2020.11.026 .
doi: 10.1053/j.ajkd.2020.11.026
pubmed: 33434591
Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017;91:227–34. https://doi.org/10.1016/j.kint.2016.09.015 .
doi: 10.1016/j.kint.2016.09.015
pubmed: 27884399
Warren B, Rebholz CM, Sang Y, Lee AK, Coresh J, Selvin E, et al. Diabetes and trajectories of estimated glomerular filtration rate: a prospective cohort analysis of the atherosclerosis risk in communities study. Diabetes Care. 2018;41:1646–53. https://doi.org/10.2337/dc18-0277 .
doi: 10.2337/dc18-0277
pubmed: 29858211
pmcid: 6054502
Anderson AH, Xie D, Wang X, Baudier RL, Orlandi P, Appel LJ, et al. Novel risk factors for progression of diabetic and nondiabetic CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021;77:56–73. https://doi.org/10.1053/j.ajkd.2020.07.011 .
doi: 10.1053/j.ajkd.2020.07.011
pubmed: 32866540
Yoshida Y, Kashiwabara K, Hirakawa Y, Tanaka T, Noso S, Ikegami H, et al. Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan. BMJ Open Diabetes Res Care. 2020;8: e000902. https://doi.org/10.1136/bmjdrc-2019-000902 .
doi: 10.1136/bmjdrc-2019-000902
pubmed: 32205326
pmcid: 7206926
Li YJ, Chen X, Kwan TK, Loh YW, Singer J, Liu Y, et al. Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A. J Am Soc Nephrol. 2020;31:1267–81. https://doi.org/10.1681/asn.2019101029 .
doi: 10.1681/asn.2019101029
pubmed: 32358041
pmcid: 7269358
Novak M, Mucsi I, Rhee CM, Streja E, Lu JL, Kalantar-Zadeh K, et al. Increased risk of incident chronic kidney disease, cardiovascular disease, and mortality in patients with diabetes with comorbid depression. Diabetes Care. 2016;39:1940–7. https://doi.org/10.2337/dc16-0048 .
doi: 10.2337/dc16-0048
pubmed: 27311494
pmcid: 5079613
Yu MK, Weiss NS, Ding X, Katon WJ, Zhou XH, Young BA. Associations between depressive symptoms and incident ESRD in a diabetic cohort. Clin J Am Soc Nephrol. 2014;9:920–8. https://doi.org/10.2215/cjn.08670813 .
doi: 10.2215/cjn.08670813
pubmed: 24677559
pmcid: 4011449
Zelnick LR, Weiss NS, Kestenbaum BR, Robinson-Cohen C, Heagerty PJ, Tuttle K, et al. Diabetes and CKD in the United States population, 2009–2014. Clin J Am Soc Nephrol. 2017;12:1984–90. https://doi.org/10.2215/cjn.03700417 .
doi: 10.2215/cjn.03700417
pubmed: 29054846
pmcid: 5718269
Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan diabetes clinical data management study (JDDM15). Nephrol Dial Transplant. 2009;24:1212–9. https://doi.org/10.1093/ndt/gfn603 .
doi: 10.1093/ndt/gfn603
pubmed: 18984626